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1Seoul National University, Korea Lymph node (LN) imaging has clinical significance because the invasion status of the
LN is crucial information for disease stratification, staging, and management. Com-
pared with conventional method, simultaneous PET/MRI using the multi-modal ima-
ging marker can offer synergistic advantages. Here, we present LN mapping using
selfdeveloped PET/MRI and novel bimodal biomarker. The SiPM-based PET insert
which has peak sensitivity of 3.4% and center volumetric resolution of 0.57 cubic mm
was developed. The PET insert was placed between the RF and gradient coil of Bruker
7T MRI. For LN targeting, 64Cu-NOTA-ironoxide-mannose, a new LN targeted dual-
modality probe yielding superior T2 contrast was used. The relaxivity of the probe was
measured by phantom study. Before the simultaneous imaging, MRI of the left and
right popliteal lymph node of an anaesthetized BALB/c mouse was acquired as the
control. 10 μL of the tracer was then injected into the left hindpaw of same mouse.
Simultaneous PET/MRI was acquired for 10 minutes after 10-min and 120-min uptake
period. The r2 of the probe was 845.3 at 7T magnetic field. The simultaneous PET/
MRI has sufficient resolution and sensitivity to imaging tiny organ like mouse LN.
A left popliteal LN in the 120-min post-injection MRI resulted in a remarkable signal
decrease compared to those in the pre-injection MRI and that was good agreement
with PET. The 10-min post-injection PET also showed clear regional activity in the
LN, but the 10-min uptake period was not sufficient to generate MR contrast. It is due
to the large difference in the sensitivities of the two modality. The simultaneous PET/
MRI is useful for in vivo imaging and bimodal imaging probe development particularly
to generating negative T2 contrast.
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